These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15630912)

  • 1. Resolution of pure red cell aplasia with continued production of low titer anti-epoetin antibodies.
    Leikis MJ; Forbes IK; McMahon LP; Becker GJ
    Clin Nephrol; 2004 Dec; 62(6):481-2. PubMed ID: 15630912
    [No Abstract]   [Full Text] [Related]  

  • 2. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.
    Casadevall N; Nataf J; Viron B; Kolta A; Kiladjian JJ; Martin-Dupont P; Michaud P; Papo T; Ugo V; Teyssandier I; Varet B; Mayeux P
    N Engl J Med; 2002 Feb; 346(7):469-75. PubMed ID: 11844847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
    Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
    Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than another.
    Macdougall IC
    Curr Med Res Opin; 2004 Jan; 20(1):83-6. PubMed ID: 14741076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin.
    Casadevall N
    Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii37-41. PubMed ID: 14608000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early onset of anti- erythropoietin antibody-mediated pure red cell aplasia after commencement of subcutaneous administration of epoetin-β].
    Tanaka A; Tsukada J; Morimoto H; Katsuragi T; Nakanishi T; Watanabe S; Hirase N; Motomura S
    Rinsho Ketsueki; 2012 Jan; 53(1):110-2. PubMed ID: 22374534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin-induced, antibody-mediated pure red cell aplasia.
    Rossert J;
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():95-9. PubMed ID: 16281965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS).
    Macdougall IC; Casadevall N; Locatelli F; Combe C; London GM; Di Paolo S; Kribben A; Fliser D; Messner H; McNeil J; Stevens P; Santoro A; De Francisco AL; Percheson P; Potamianou A; Foucher A; Fife D; Mérit V; Vercammen E;
    Nephrol Dial Transplant; 2015 Mar; 30(3):451-60. PubMed ID: 25239637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pure red cell aplasia and antibodies against erythropoietin. Doubts still remain].
    Peces R
    Nefrologia; 2003; 23(4):295-6, 297. PubMed ID: 14558327
    [No Abstract]   [Full Text] [Related]  

  • 10. Epoetin-induced autoimmune pure red cell aplasia.
    Casadevall N
    Hematol J; 2004; 5 Suppl 3():S104-9. PubMed ID: 15190289
    [No Abstract]   [Full Text] [Related]  

  • 11. Pure red-cell aplasia due to anti-erythropoietin antibodies.
    Eckardt KU; Casadevall N
    Nephrol Dial Transplant; 2003 May; 18(5):865-9. PubMed ID: 12686654
    [No Abstract]   [Full Text] [Related]  

  • 12. Epoetin-induced autoimmune pure red cell aplasia.
    Casadevall N; Eckardt KU; Rossert J
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S67-9. PubMed ID: 15938038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced autoimmune red-cell aplasia.
    Bunn HF
    N Engl J Med; 2002 Feb; 346(7):522-3. PubMed ID: 11844855
    [No Abstract]   [Full Text] [Related]  

  • 14. Feasibility of a multiplex flow cytometric bead immunoassay for detection of anti-epoetin alfa antibodies.
    Ferbas J; Thomas J; Hodgson J; Gaur A; Casadevall N; Swanson SJ
    Clin Vaccine Immunol; 2007 Sep; 14(9):1165-72. PubMed ID: 17634512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure red-cell aplasia caused by the antibody to recombinant erythropoietin, epoetin-beta, in a Japanese patient with chronic renal failure.
    Shinohara K; Mitani N; Miyazaki M; Sakuragi S; Matsuda K; Ogawara S; Saito T; Kaneoka H; Ooji T
    Am J Hematol; 2005 Jan; 78(1):15-20. PubMed ID: 15609276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pure red cell aplasia (PRCA) induced by anti-EPO antibodies: epidemiology, diagnosis and treatment].
    Janda K; Kraśniak A; Krzanowski M; Sułowicz W
    Przegl Lek; 2010; 67(3):187-91. PubMed ID: 20687383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.
    Bennett CL; Cournoyer D; Carson KR; Rossert J; Luminari S; Evens AM; Locatelli F; Belknap SM; McKoy JM; Lyons EA; Kim B; Sharma R; Costello S; Toffelmire EB; Wells GA; Messner HA; Yarnold PR; Trifilio SM; Raisch DW; Kuzel TM; Nissenson A; Lim LC; Tallman MS; Casadevall N
    Blood; 2005 Nov; 106(10):3343-7. PubMed ID: 16099877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure red-cell aplasia induced by anti-erythropoietin antibodies in peritoneal dialysis.
    Coronel F; García-Mena M; Martínez R
    Clin Nephrol; 2004 Feb; 61(2):155-8. PubMed ID: 14989637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins.
    Weber G; Gross J; Kromminga A; Loew HH; Eckardt KU
    J Am Soc Nephrol; 2002 Sep; 13(9):2381-3. PubMed ID: 12191983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights.
    Macdougall IC; Roger SD; de Francisco A; Goldsmith DJ; Schellekens H; Ebbers H; Jelkmann W; London G; Casadevall N; Hörl WH; Kemeny DM; Pollock C
    Kidney Int; 2012 Apr; 81(8):727-32. PubMed ID: 22336988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.